3 results
The primary objective of this study is to determine if ambrisentan is effective in delaying disease progression and death in subjects with IPF.Secondary objectives include evaluation of the safety and effect of ambrisentan on development of…
The first aim of the study is to investigate whether DCS addition to exposure therapy enhances symptom reduction in PD+AGO. The second objective of the study is to establish the optimal timing of administration of DCS (30 minutes before or directly…
The primary objective is to determine the safety, tolerability and feasibility of pre-surgical lyso-thermosensitive liposomal doxorubicin (ThermoDox) + MR-HIFU induced local hyperthermia therapy in metastatic breast cancer. The secondary objectives…